Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Tarpon Springs, Florida 34688


Purpose:

To compare the efficacy of twice-daily topical bromfenac (Xibrom) ophthalmic solution alone versus twice-daily topical Xibrom with prednisolone acetate 1% three-times daily on visual acuity and OCT measurements.


Criteria:

Inclusion Criteria: - Male or female at least 18 years of age. - Expectation of 20/25 best corrected visual acuity (BCVA) post-operatively. - Patients should be in good general health and devoid of recognized risk factors for CME. - Patients with systemic diseases are eligible only if there were no ocular manifestations of the disease (specifically diabetics without retinopathy) - Patients must be likely to provide informed consent, take study medications as directed, and complete all study visits - Only one eye of each treated patient may be included in the study Exclusion Criteria: - Any known contraindications to any study medication or their component - Presence of uncontrolled systemic disease - Required use of other ocular medications during the study o Artificial tears may be used - Diabetics with any clinically evident or history of retinopathy - Individuals with age-related macular changes, epi-retinal membranes, other retino-vascular diseases and/or other macular disorders thought to have a less than 20/25 surgical outcome expectation - Abnormal pre-operative OCT (if obtainable)


NCT ID:

NCT00698724


Primary Contact:

Principal Investigator
James Gills, MD
St. Luke's Cataract and Laser Institute


Backup Contact:

N/A


Location Contact:

Tarpon Springs, Florida 34688
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.